Using a coincidence counting system and a single bolus injection of 84RbCl, the effect of sublingual nitroglycerin (0.6 mg) on myocardial blood flow (MBF) in normal human subjects was studied. Concomitant pressure time per minute work of the heart was calculated as the product of heart rate, systolic mean pressure, and systolic ejection period. Seventeen subjects were studied. In seven, repeat measurements were made 3 minutes after administration of nitroglycerin and in 10 subjects 10 minutes after the drug was given.
T HE REPORTS dealing with the effect of sublingual nitroglycerin on coronary blood flow (MBF) in normal human subjects are conflicting. Some investigators state that the drug increases MBF in normal humans From 932 Oxygen requirements of myocardium but not in patients with coronary artery disease,' 3 the implication being that a 'normal" response to nitroglycerin is one of increased MBF. The data of Bernstein and associates,4 however, shows that 3 to 8 minutes after the administration of 0.4 mg of nitroglycerin sublingually six patients with normal coronary arteries, as demonstrated by coronary arteriography, had an increased MBF whereas 12 had decreased MBF.
A number of explanations can be offered for the variance in the reported effects of sublingual nitroglycerin on MBF in normal subjects. Honig and associates,5 pointed out that nitroglycerin produces a rapidly fluctuating unsteady state and, therefore, techniques should be used which require minimal measurement time to determine MBF. In addition, Circulation, Volume XXXVII, June 1968 each technique for measuring coronary flow has its own inherent limitations other than the time required to make the measurement. Both the nitrous oxide and clearance methods used in the previous studies may be insensitive to poorly perfused areas.6 7 Both also assume an arbitrary amount of tissue perfused ( 100 g of left ventricle) so that an altered perfusion-flow ratio could introduce an error. 7 With the development of a technique for the measurement of MBF in man utilizing a coincidence counting system and a single bolus injection of 84rubidium ( 84RbCl ), 8, 9 which permits measurements during a nonsteady state, and in terms of milliliters per minute per total heart, it became possible to restudy the problem. The diagnostic potential inherent in a differential response in MBF to nitroglycerin between patients with and without coronary artery disease was the stimulus for the study. Methods Seventeen normal subjects were studied. The resting electrocardiograms were normal in all. The age range was from 19 to 31 years with a mean age of 23 years. There were 12 males and five females in the group. Blood pressure was measured via an indwelling 17-gauge Cournand needle inserted in the brachial artery, connected to a Statham P-23-D strain gauge and recorded on an Electronics for Medicine recorder (model DR-8). The mean systolic arterial pressure (SM) was obtained by planimetric integration and the mean arterial pressure by electric integration. Pressure time per minute (PTM) expressed in mm Hg per second per minute was obtained as the product of the SM, heart rate, and systolic ejection period (SEP). SEP in seconds was measured from the pressure records as the time interval between the onset of the brachial arterial pulse and the dicrotic notch and was expressed as the average figure of at least six beats taken at the extremes of respiratory fluctuation. Heart rate was measured from a simultaneously recorded electrocardiogram.
The cardiac output (CO) was measured by using 84RbCl as the indicator.
Myocardial blood flow in milliliters per minute per total heart was calculated using the formula:
Circulation, Volame XXXVII, Junre 1968 where q (t) is the myocardial uptake of 84RbCl as measured by a coincidence counting system x (American Science and Engineering) andf Ao a (t) dt represents the concentration of the isotope in arterial blood during the first circulation, determined by extrapolation after recirculation begins. The theoretical basis of this formulation and experimental verification has been previously reported in detail. 8 Left ventricular minute work (LVW) in kilogram meters per minute was calculated as being equal to: 13.6 X BPSm X CO 1000 Control determinations were made prior to the administration of nitroglycerin. In seven subjects repeat measurements were made 3 min after the sublingual administration of 0.6 mg of the drug. In 10 subjects the measurements were repeated at 10 min after the same amount of nitroglycerin.
The time periods were chosen to correspond as closely as possible to those of the previous investigators,2-4 using either a clearance tech-nique4 or methods requiring a steady state.2' 3 Table 1 lists the hemodynamic responses of seven normal subjects 3 min after the sublingual administration of 0.6 mg of nitroglycerin and table 2 shows the responses measured 10 min after the drug. There were significant decreases, when considered as the differences between the means of paired data, in systolic (P < 0.005), mean (P < 0.005), and systolic mean (P < 0.005) arterial pressures and LVW (P < 0.05) 3 min after nitroglycerin. Heart rate (P <0.005), PTM (P < 0.005), and MBF (P < 0.05) were increased. Ten minutes after nitroglycerin, CO was decreased (P < 0.05) as was PTM (P < 0.05) and MBF (P < 0.005). The 10-min data were also calculated as significant differences between the means of paired data for CO, PTM, and MBF.
Results
The direction of the change in MBF was not predictable for any one subject. Four subjects in the 3-min group showed increased MBF while three had decreased MBF. There was, however, a significant correlation (r= 933 co 0
if)0 C')) CO 10Ncl 00 0) co 00 C') 00 C'e) 00 Co- 0.9740 P<0.001) for the entire 17 subjects between the directional changes in MBF and PTM when analyzed as paired data. This relationship is shown in figure 1 . There was also a significant correlation (r = 0.9313, P <0.001) between PTM and MBF when analyzed as paired data for the 10 subjects who demonstrated decreased MBF.
Discussion
The hemodynamic responses to nitroglycerin demonstrated in this study are in general agreement with those previously reported for normal subjects. Reduction in systolic, mean, and systolic mean arterial pressures and LVW are the usual findings after the sublingual administration of nitroglycerin.3 10 11 PTM has been shown either to increase'0 or decrease" 3 to 5 min following administration of nitroglycerin. Further correlation of hemodynamic measurements other than PTM and MBF with similar observations in previous studies was not considered pertinent to our study nor would it be feasible; for there is considerable variation in experimental time periods, doses of nitroglycerin, position of subjects, and methodological factors from study to study.
Before considering the significance of the MBF and PTM measurements, the validity of the methods employed should be discussed.
Estimation of the ventricular systolic duration from a brachial artery record is a possible source of inaccuracy, and the quantitative indices derived therefrom (PTM) should, therefore, be interpreted with caution.10 However, the directional or qualitative changes from the resting values to the postnitroglycerin measurements are probably valid as both would be influenced by the same methodological factors. The SEP was included because of the work of Robinson12 which suggests that, when cardiac work is to be assessed, heart rate, ejection time, and arterial pressure must all be taken into consideration, although it is convenient and justified to consider only the rate-pressure product in most circumstances.
The method of measuring MBF is unique and is difficult to validate in the human by other techniques. Chwojnik and associates,13 using an identical concept but different instrumentation and isotope, obtained comparable values for resting MBF in normal human subjects. The advantages of this technique for the study of the effect of nitroglycerin are as follows: (1) the measurements of MBF can be made in an unsteady state, (2) unperfused areas affect the total MBF measurement by adding a zero value to the myocardial count,9' 13 and (3) a constant amount of myocardium is seen by the counters. In the normal-sized heart, the MBF determination is in terms of milliliters per minute per total heart.9
It is important to consider the possible effects of nitroglycerin on the extraction of 84Rb by the heart and total body, as the technique for MBF measurement utilized in this study is dependent for quantitation on the equality of the two extraction ratios. The total body extraction and myocardial extraction ratios could differ widely, however, without affecting the qualitative measurement of MBF; for the total clearance of 84Rb by the myocardium would continue to give a reliable estimate of directional change in coronary flow.14 As quantitation of flow was not a primary aim in this study, the effect of nitro-Circulation, Volume XXXVII, June 1968 936 MYOCARDIAL BLOOD FLOW glycerin on total body and myocardial extraction ratios was not measured.
With the above reservations in mind, the data from this study suggest that a measurement of MBF at 3 or 10 min following the sublingual administration of 0.6 mg of nitroglycerin will not distinguish patients with coronary artery disease from normal subjects. Perhaps measurements made during the first minute might be discriminatory. In the absence of coronary arteriograms, the "normality" of our subjects could be questioned. The mean age of the group, however, is such that it would be unlikely that 10 of the 17 subjects had coronary disease and, thus, a decreased MBF in response to nitroglycerin.
The data do suggest, in agreement with the work of McGregor and Fam,15 that nitroglycerin does not affect the autoregulatory vessels of the heart. With autoregulation intact, MBF should be regulated by myocardial oxygen requirements16 and a correlation between MBF and measurements reflecting myocardial 02 consumption would be expected.'7 18 While PTM work of the heart is not the sole determinant of myocardial oxygen requirement, it is a reflection of the tension developed by the myocardium and the number of times this tension is developed per minute provided the ventricular volume is not appreciably altered.'9 The PTM and the level of myocardial contractility are the most important determinants of the minute oxygen consumption of the heart.20 Although contractility was not measured in this study, other workers have demonstrated a decrease in contractility 5 min following sublingual nitroglycerin (0.6 mg)-.-On the basis of this information, it would be unlikely that contractility changes would reverse the direction of the oxygen requirements of the heart in those subjects who decreased the PTM; for both determinants of myocardial 02 consumption would be operating in the same direction. In addition, the sublingual administration of nitroglycerin has been demonstrated to decrease ventricular dimensions.2' This effect would also result in a reduction in the heart's oxygen demands. It would not Circulation, Volume XXXVII, June 1968 be possible to state which of the two determinants, tension or contractility, was influencing myocardial 02 requirements to the greatest degree in those subjects with increased PTM.
